Karen Del Rosario
About Karen Del Rosario
Karen Del Rosario is the Associate Director of Drug Product Strategic Innovation at Bristol Myers Squibb, with a background in chemical and biomedical engineering and extensive experience in product development at Procter & Gamble.
Current Role at Bristol Myers Squibb
Karen Del Rosario currently serves as the Associate Director of Drug Product Strategic Innovation - Hematology & Early Products Research at Bristol Myers Squibb. She operates from the company’s office in Summit, New Jersey, United States.
Previous Experience at Procter & Gamble
Prior to her role at Bristol Myers Squibb, Karen Del Rosario spent nine years at Procter & Gamble. She held the position of Senior Research and Development Engineer for the NA Home Made Simple project from 2010 to 2019 in Cincinnati, OH. She also worked as a Products Research Engineer and Process Formulation Engineer in 2006 and again briefly in 2009 in the Cincinnati, Ohio area.
Educational Background
Karen Del Rosario possesses a Bachelor of Science degree in Chemical Engineering from the University of Kentucky, which she completed in 2010 after starting in 2007. She also holds a Master of Science degree in Bioengineering and Biomedical Engineering from Case Western Reserve University.
Notable Projects and Innovations
While at Procter & Gamble, Karen Del Rosario led significant projects in the consumer health sector. She played a crucial role in the development of ZzzQuil, which became the top sleep aid in the market, and led the relaunch of Sinex and VapoInhaler, achieving market leadership within 12 weeks. She constructed P&G’s first 'sleep consumer' segmentation and identified innovations for better sleep solutions, including a 10-year innovation pipeline that featured products like ZzzQuil gummies. Additionally, Karen co-developed the first clinical sleep study for occasional sleeplessness sufferers, overseeing protocol development and data analysis, and created sensory modeling projections to forecast consumer response efficiently.